Skip to main content

Want a detailed portfolio tracker?

Bicara Therapeutics (BCAX) P/E (2024 - 2026)

Bicara Therapeutics (BCAX) P/E from Sep 30, 2024 to Jul 20, 2026. The TTM Bicara Therapeutics (BCAX) P/E is -10.11. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Bicara Therapeutics (BCAX)

YearP/EChange
2026-10.11+50.40%
2025-6.72-72.75%
2024-24.66N/A

Comparison Bicara Therapeutics (BCAX) P/E with competitors

Bicara Therapeutics (BCAX) P/E is -10.11.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.04%
ENLVEnlivex Ltd0.07-100.74%
FGENFibroGen Inc0.24-102.37%
CHRSCoherus Biosciences Inc0.85-108.39%
FBIOFortress Biotech Inc0.95-109.39%
ORMPOramed Pharmaceuticals Inc1.50-114.87%
AGENAgenus Inc3.01-129.77%
INVAInnoviva Inc3.15-131.20%
VXRTVaxart Inc3.55-135.11%
CRMDCorMedix Inc3.63-135.89%
CVACCureVac N.V.4.45-143.97%
GLPGGalapagos NV4.86-148.06%
SRPTSarepta Therapeutics Inc4.88-148.29%
ABEOAbeona Therapeutics Inc5.39-153.29%
ABUSArbutus Biopharma Corp5.60-155.34%
ZVRAZevra Therapeutics Inc5.89-158.23%
SPROSpero Therapeutics Inc6.23-161.60%
CGENCompugen Ltd6.31-162.45%
RIGLRigel Pharmaceuticals6.87-167.97%
SLXNSilexion Therapeutics Corp7.30-172.16%
OMEROmeros Corporation9.26-191.58%
AUPHAurinia Pharmaceuticals Inc9.58-194.80%
PLXProtalix BioTherapeutics Inc10.89-207.72%
ACADAcadia Pharmaceuticals Inc11.73-216.00%
TBPHTheravance Biopharma Inc12.26-221.28%
ADMAAdma Biologics Inc12.42-222.82%
HRMYHarmony Biosciences Holdings Inc13.82-236.69%
SABSSAB Biotherapeutics Inc14.14-239.82%
NAGENiagen Bioscience Inc14.82-246.56%
INCYIncyte Corp15.82-256.50%
REGNRegeneron Pharmaceuticals Inc15.86-256.83%
PBYIPuma Biotechnology Inc17.32-271.27%
CPRXCatalyst Pharmaceuticals Inc17.44-272.49%
EXELExelixis Inc17.54-273.46%
TGTXTG Therapeutics Inc18.97-287.59%
MDXGMimedx Group Inc20.55-303.28%
XOMAXOMA Royalty Corp22.87-326.25%
ARGXArgen X SE24.30-340.33%
CTMXCytomX Therapeutics Inc24.82-345.51%
XOMAOXOMA Royalty Corp25.34-350.69%
HALOHalozyme Therapeutics Inc25.62-353.44%
XOMAPXOMA Royalty Corp25.67-353.90%
VRTXVertex Pharmaceuticals Inc27.99-376.90%
RPRXRoyalty Pharma plc - Class A28.69-383.75%
SLNOSoleno Therapeutics Inc29.02-386.99%
ASNDAscendis Pharma A/S30.09-397.58%
LGNDLigand Pharmaceuticals Inc - Class B37.91-474.99%
APLSApellis Pharmaceuticals Inc39.02-485.96%
BMRNBiomarin Pharmaceutical Inc42.21-517.52%
KRYSKrystal Biotech Inc45.34-548.49%
ONCBeiGene Ltd69.54-787.82%
PHARPharming Group N.V.75.03-842.08%
TECHBio-Techne Corp101.96-1108.47%
VCELVericel Corp109.92-1187.23%
ALNYAlnylam Pharmaceuticals Inc117.96-1266.79%
GMABGenmab140.29-1487.62%
TLXTelix Pharmaceuticals Ltd162.15-1703.86%
CORTCorcept Therapeutics Inc212.86-2205.38%